Bausch Health Companies Inc., formerly known as Valeant Pharmaceuticals International, is a multinational pharmaceutical and medical device company with a significant presence in the healthcare industry. Headquartered in Laval, Quebec, Canada, the company is known for its diverse portfolio of pharmaceuticals, over-the-counter products, and medical devices that address various medical needs and conditions.
Bausch Health's portfolio covers a wide range of therapeutic areas, including dermatology, ophthalmology, gastrointestinal disorders, and more. The company's products are designed to improve patient health and well-being through innovative treatments and solutions that meet the evolving needs of patients and healthcare professionals.
The company's commitment to research and development has led to the creation of numerous proprietary pharmaceuticals and medical devices. Bausch Health's investments in innovation aim to provide patients with cutting-edge therapies and technologies that enhance their quality of life.
Bausch Health has been recognized for its transformative business strategies and acquisitions. The company has pursued growth through strategic acquisitions of complementary companies and products, allowing it to expand its offerings and geographic reach.